Dashboard
1
Positive results in Mar 26
- OPERATING CASH FLOW(Y) Highest at CNY 8,978.07 MM
- DEBT-EQUITY RATIO (HY) Lowest at -12.59 %
- CASH AND EQV(HY) Highest at CNY 22,112.38 MM
2
With ROE of 22.76%, it has a very attractive valuation with a 3.69 Price to Book Value
3
Consistent Returns over the last 3 years
Stock DNA
Pharmaceuticals & Biotechnology
CNY 100,555 Million (Large Cap)
16.00
NA
2.15%
-0.13
19.28%
2.86
Revenue and Profits:
Net Sales:
6,295 Million
(Quarterly Results - Mar 2026)
Net Profit:
1,836 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
7.34%
0%
7.34%
6 Months
30.59%
0%
30.59%
1 Year
40.28%
0%
40.28%
2 Years
60.68%
0%
60.68%
3 Years
89.73%
0%
89.73%
4 Years
22.54%
0%
22.54%
5 Years
-3.07%
0%
-3.07%
Zhejiang NHU Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
19.25%
EBIT Growth (5y)
15.64%
EBIT to Interest (avg)
16.35
Debt to EBITDA (avg)
0.62
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
0.52
Tax Ratio
13.87%
Dividend Payout Ratio
45.25%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
17.26%
ROE (avg)
16.94%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
3.69
EV to EBIT
14.48
EV to EBITDA
11.94
EV to Capital Employed
3.81
EV to Sales
5.23
PEG Ratio
0.27
Dividend Yield
1.82%
ROCE (Latest)
26.32%
ROE (Latest)
22.76%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
6,294.70
5,609.30
12.22%
Operating Profit (PBDIT) excl Other Income
2,146.50
2,115.50
1.47%
Interest
44.70
61.90
-27.79%
Exceptional Items
5.30
35.00
-84.86%
Consolidate Net Profit
1,835.70
1,447.90
26.78%
Operating Profit Margin (Excl OI)
341.00%
274.90%
6.61%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 12.22% vs 1.22% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 26.78% vs -16.44% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
22,088.50
21,476.30
2.85%
Operating Profit (PBDIT) excl Other Income
9,854.70
9,149.30
7.71%
Interest
231.10
290.80
-20.53%
Exceptional Items
-59.20
-45.10
-31.26%
Consolidate Net Profit
6,802.10
5,896.90
15.35%
Operating Profit Margin (Excl OI)
341.70%
322.00%
1.97%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 2.85% vs 42.68% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 15.35% vs 116.37% in Dec 2024
About Zhejiang NHU Co. Ltd. 
Zhejiang NHU Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






